Cardio-cerebrovascular disease history complicates hematopoietic cell transplant outcomes
(Cactus Communications) Transplanting hematopoietic stem cells to treat cancers and other conditions carries with it the risk of developing cardio-cerebrovascular diseases (CCVD)--disorders affecting the blood vessels of the heart and brain. Although research on post-transplant CCVD is extensive, there is paucity of knowledge on the effects of pre-transplant CCVD on transplant outcomes. Now researchers in China suggest pre-transplant CCVD indirectly affects patient mortality and survival following transplant through their strong association with post-transplant CCVD. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 22, 2021 Category: International Medicine & Public Health Source Type: news

AI model identifies SARS-CoV-2 from blood tests, chest x-rays
An artificial intelligence (AI) model that analyzed data from blood tests an...Read more on AuntMinnie.comRelated Reading: Vuno inks deal with Samsung integrating AI with mobile x-ray AI may predict heart disease risk on chest x-ray Chest x-ray may predict risk of hospitalization in COVID-19 AI of x-ray predicts prognosis of COVID-19 patients Daily chest x-rays not needed in COVID-19 patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 16, 2021 Category: Radiology Source Type: news

Death disruptor: how an Australian funnel-web spider may help human hearts
University of Queensland researchers are investigating if protein in venom of Fraser Island spider can stop cardiac cells dyingA protein in the venom of adeadly Australian funnel-web spider may be able to reduce cardiac damage from heart attacks and extend the life of donor hearts used in transplants, according to new research.Venom from the Fraser Island funnel-web, named for the south-east Queensland island where it is found, contains aprotein known as Hi1a.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 15, 2021 Category: Science Authors: Donna Lu Tags: Heart disease Science Medical research Australia news Queensland Source Type: news

AHA News: Genetic Problem Led to a Heart Transplant at 24. Her New Heart Has a Genetic Problem, Too.
WEDNESDAY, July 14, 2021 (American Heart Association News) -- At 13, Leilani Graham was running on the treadmill in her garage when she suddenly collapsed. Her mother, who was supposed to be gone, heard a bizarre moaning sound coming from the garage... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 14, 2021 Category: General Medicine Source Type: news

AHA News: Genetic Problem Led to a Heart Transplant at 24. Her New Heart Has a Genetic Problem, Too.
Title: AHA News: Genetic Problem Led to a Heart Transplant at 24. Her New Heart Has a Genetic Problem, Too.Category: Health NewsCreated: 7/14/2021 12:00:00 AMLast Editorial Review: 7/14/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - July 14, 2021 Category: Cardiology Source Type: news

RSIP Vision launches MRI segmentation software
Computer software and artificial intelligence company RSIP Vision has release...Read more on AuntMinnie.comRelated Reading: RSIP Vision debuts prostate AI registration tool RSIP releases new CT segmentation software for orthopedics RSIP Vision launches coronary artery tool RSIP Vision unveils AI-based image segmentation tool RSIP Vision launches new heart POC ultrasound (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 12, 2021 Category: Radiology Source Type: news

Mayo Clinic Minute: Why bone marrow donor diversity is needed
Bone marrow transplants are procedures that infuse healthy blood stem cells into your body to replace damaged or diseased bone marrow. Just like people in need of solid organ transplants, such as hearts or kidneys, people in need of a bone marrow transplant have to find a matching donor. Dr. Ernesto Ayala, a Mayo Clinic hematologist and oncologist, says bone marrow donations from people of all races and ethnicities are essential in order to help… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 8, 2021 Category: Databases & Libraries Source Type: news

What Problems are Ciliopathies Associated With?
Discussion Nephronophthisis (NPHP) one cause of end-stage renal disease (ESRD) usually occurring before age 30 years. NPHP is a non-motile ciliopathy affecting cellular sensing in the renal tubular epithelium. See To Learn More below. The incidence varies according to location with 1:1 million in the US but 1:50,000 in Finland. There are 3 subtypes: Infantile Occurs usually within 1 year of life Enlarged kidneys and severe hypertension In utero can have oligohydramnios problems such as pulmonary hypoplasia, facial dysmorphisms, limb contractures Extra-renal problems include congenital heart disease, liver fibrosis, recur...
Source: PediatricEducation.org - July 5, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

TJ Olsen rings bell and goes home after successful heart transplant
Bells ringing, drums pounding, and hearts singing. After a successful heart transplant, TJ Olsen, son of former Carolina Panther Greg Olsen and Kara Olsen, went home. There is simply no greater feeling than seeing a happy, healthy patient go home with their family. Learn more about Atrium Health Levine Children’s pediatric heart surgery and cardiology program. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 2, 2021 Category: Pharmaceuticals Authors: Atrium Health Source Type: news

NIDCR's Summer 2021 E-Newsletter
Having trouble viewing this email? View it as a Web page. NIDCR's Summer 2021 E-Newsletter In this issue: NIDCR News Funding Opportunities & Related Notices NIH/HHS News Subscribe to NICDR News Science Advances   Grantee News   NIDCR News NIDCR to Release Report on Oral Health in America As a 20-year follow-up to the seminal Oral Health in America: A Report of the Surgeon General, NIDCR will release Oral Health in America: Advances and Challenges in the fall of 2021. The report will illuminate new directions...
Source: NIDCR Science News - July 1, 2021 Category: Dentistry Source Type: news

For transplant patients, COVID-19 vaccination presents a different uncertainty
(University of California - San Diego) Researchers at UC San Diego Health have launched a pair of clinical trials to study the immune response of COVID-19 vaccinated transplant recipients of bone marrow and solid organs, such as the heart, lung, liver and kidney. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 1, 2021 Category: Infectious Diseases Source Type: news

Pumped to assist the heart with an artificial aorta
(Ecole Polytechnique F é d é rale de Lausanne) Scientists from EPFL and University of Bern have successfully implanted - in vivo - their first artificial tubular muscle that augments the aorta and assists cardiac function in pumping blood. Based on these results, the Werner Siemens Foundation has provided the green-light for granting an extra 8 million CHF over 8 years to develop artificial muscles for human disorders. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 30, 2021 Category: International Medicine & Public Health Source Type: news

WHO guidance on Artificial Intelligence  to improve healthcare, mitigate risks worldwide 
Artificial Intelligence (AI) holds “enormous potential” for improving the health of millions around the world if ethics and human rights are at the heart of its design, deployment, and use, the head of the UN health agency said on Monday.  (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - June 28, 2021 Category: International Medicine & Public Health Source Type: news

What Types of New Therapies are Available for Cystic Fibrosis?
Discussion Cystic fibrosis (CF) was identified in 1938 by Dr. Dorothy Andersen who described 49 patients with pancreatic insufficiency. Since that time significant achievements in the knowledge about the disease and treatments for patients have changed the mortality from a few months to patients living into middle adulthood or even later. Quality of life for patients and their families and friends has also markedly improved. CF is the classic Mendelian autosomal recessive genetic disorder which is a worldwide disorder but affects people of north European ancestry more often where the main mutation is more common. There are...
Source: PediatricEducation.org - June 28, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Elderly Heart Transplant Patients Have 5-Year Survival Similar to Younger Recipients Elderly Heart Transplant Patients Have 5-Year Survival Similar to Younger Recipients
Survival of elderly heart transplant recipients at 5 years is similar to that of younger recipients even though older adults are more likely to get organs from higher-risk donors, a recent study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 24, 2021 Category: Consumer Health News Tags: Transplantation News Source Type: news

Providence Heart Institute receives key approval for heart transplants
"It ’s the end of the beginning" for the transplant program. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 23, 2021 Category: American Health Authors: Elizabeth Hayes Source Type: news

Providence Heart Institute receives key approval for heart transplants
"It ’s the end of the beginning" for the transplant program. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 23, 2021 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

Janssen Submits New Drug Application to U.S. FDA for XARELTO ® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
RARITAN, NJ, June 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the use of XARELTO® (rivaroxaban) in pediatric patients. The NDA seeks two pediatric indications: treatment of venous thromboembolism (VTE, or blood clots) and reduction in the risk of recurrent VTE in patients aged birth to less than 18 years of age after at least five days of initial parenteral anticoagulant treatment; and thromboprophylaxis (prevention of blood clots) in patients aged 2 years and older with co...
Source: Johnson and Johnson - June 23, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

AHA News: At 17, He Received a New Heart. By 23, He Began Transitioning.
FRIDAY, June 18, 2021 (American Heart Association News) -- For most transgender people, starting hormone therapy requires a therapist's approval. As the recipient of a new heart, Maddox Jones also needed his transplant team's OK. " It was a long and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 18, 2021 Category: General Medicine Source Type: news

New artificial heart shows promising results in 'auto-mode' -- initial clinical experience reported in ASAIO Journal
(Wolters Kluwer Health) An experimental artificial heart includes an autoregulation control mechanism, or Auto-Mode, that can adjust to the changing needs of patients treated for end-stage heart failure. Outcomes in the first series of patients managed with the new heart replacement pump in Auto-Mode are presented in the ASAIO Journal, official journal of the American Society for Artificial Internal Organs. The journal is published in the Lippincott portfolio by Wolters Kluwer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 18, 2021 Category: International Medicine & Public Health Source Type: news

Rapid exclusion of COVID-19 infection using AI, EKG technology
(Mayo Clinic) Artificial intelligence (AI) may offer a way to accurately determine that a person is not infected with COVID-19. An international retrospective study finds that infection with SARS-CoV-2, the virus that causes COVID-19, creates subtle electrical changes in the heart. An AI-enhanced EKG can detect these changes and potentially be used as a rapid, reliable COVID-19 screening test to rule out COVID-19 infection. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 15, 2021 Category: Infectious Diseases Source Type: news

Rapid exclusion of COVID-19 infection using AI, EKG technology
ROCHESTER, Minn. -- Artificial intelligence (AI) may offer a way to accurately determine that a person is not infected with COVID-19. An international retrospective study finds that infection with SARS-CoV-2, the virus that causes COVID-19, creates subtle electrical changes in the heart. An AI-enhanced EKG can detect these changes and potentially be used as a [...] (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - June 15, 2021 Category: Hospital Management Source Type: news

AI analysis of SPECT MPI scans can predict future cardiac events
The combination of artificial intelligence (AI) and SPECT myocardial perfusio...Read more on AuntMinnie.comRelated Reading: Machine learning plus CT boosts prediction of major coronary events Report charts 80% drop in cardiac SPECT during COVID-19 Machine-learning model predicts adverse cardiac outcomes AI predicts heart attack, stroke on cardiac MRI Deep learning advances SPECT MPI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 12, 2021 Category: Radiology Source Type: news

Janssen Announces Results from Phase 3 MAIA Study Showing Significant Overall Survival Benefits for Treatment with DARZALEX ® (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma Who are Transplant Ineligible
Raritan, N.J., June 12, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced overall survival (OS) results from the Phase 3 MAIA (NCT02252172) study showing the addition of DARZALEX® (daratumumab) to lenalidomide and dexamethasone (D-Rd) resulted in a statistically significant survival benefit over lenalidomide and dexamethasone (Rd) alone in patients with newly diagnosed multiple myeloma (NDMM) who were ineligible for autologous stem cell transplant (ASCT) and were treated to progression.[1] These data were featured in the European Hematology Association (EHA) 2021 Virtual Press Briefin...
Source: Johnson and Johnson - June 12, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Old Age No Bar to Successful Heart Transplant, Study Finds
FRIDAY, June 11, 2021 -- People over 70 are far less likely to be considered for or to receive a new heart -- even though new research suggests their survival rates after transplant are similar to those of younger patients. For the study, the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 11, 2021 Category: General Medicine Source Type: news

Old Age No Bar to Successful Heart Transplant, Study Finds
Title: Old Age No Bar to Successful Heart Transplant, Study FindsCategory: Health NewsCreated: 6/11/2021 12:00:00 AMLast Editorial Review: 6/11/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - June 11, 2021 Category: Cardiology Source Type: news

Mayo Clinic Q and A: The connection between skin care and transplant
DEAR MAYO CLINIC: About a year ago, I had a heart transplant and I've been doing well since. At a recent follow-up visit, my transplant doctor recommended a skin check with a dermatologist. What's the connection? ANSWER: It's always a good idea to be evaluated by a dermatologist for a baseline skin check, regardless of your past [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 10, 2021 Category: Databases & Libraries Source Type: news

Heart Transplant Outcomes Comparable in Advanced Age
WEDNESDAY, June 9, 2021 -- Survival up to five years after a heart transplant is similar for patients aged 70 years and older and those younger than 70 years, according to a study published online June 9 in the Journal of the American Geriatrics... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 9, 2021 Category: Pharmaceuticals Source Type: news

New analysis examines survival of older patients who undergo heart transplantation
(Wiley) Advanced age is often considered a contraindication for heart transplantation, but a new study published in the Journal of the American Geriatrics Society (JAGS) found that post-heart transplant survival among recipients aged ?70 years is not inferior to that of younger recipients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 9, 2021 Category: International Medicine & Public Health Source Type: news

Heart transplants: Age is no barrier to successful surgery
(American Geriatrics Society) A new study published in the Journal of the American Geriatrics Society suggests that survival rates after heart transplant surgery are similar in adults ages 18 to 69 and adults ages 70 and older. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 9, 2021 Category: International Medicine & Public Health Source Type: news

Regaining Cardiorespiratory Fitness Post-Heart Transplantation Regaining Cardiorespiratory Fitness Post-Heart Transplantation
Participation in cardiac rehabilitation exercise programs has proven beneficial in post-heart transplant patients, but more research is needed to determine optimal exercise regimens.ACC.org (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 2, 2021 Category: Cardiology Tags: Cardiology Journal Article Source Type: news

Janssen Highlights Commitment to Advancing Transformative Innovations in Oncology with Scientific Updates from Deep, Diverse Pipeline and Portfolio at ASCO and EHA Virtual Scientific Programs
June 1, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 30 company-sponsored studies, including six oral presentations, will be featured during the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, June 4-8. Janssen presentations will include new data and updates for both approved and investigational therapeutics that are being studied for the treatment of various solid tumors and blood cancers. Immediately following ASCO, additional data will be featured during the European Hematology Association (EHA) Virtual Congress, June 9-17. A ...
Source: Johnson and Johnson - June 1, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

UPMC moving ahead with 2 specialty hospitals in Pittsburgh
UPMC is moving ahead with its plans for two big specialty hospitals, a heart and transplant hospital in Oakland and a cancer hospital in Shadyside. Both hospitals were part of a $2 billion commitment made by the Pittsburgh-based health system in late 2018, when it announced three specialty hospitals. Progress on the heart and transplant hospital and the UPMC Hillman Cancer Hospital had been delayed even before the Covid-19 pandemic hit but th e third, the UPMC Vision and Rehabilitation Tower in Uptown… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 28, 2021 Category: Health Management Authors: Paul J. Gough Source Type: news

Updated Data Demonstrate Significant Improvement in Hematologic Complete Response with DARZALEX FASPRO ® (daratumumab and hyaluronidase-fihj) in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
RARITAN, N.J., May 26, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced updated results from the Phase 3 ANDROMEDA study, which evaluated DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for the treatment of patients with newly diagnosed light chain (AL) amyloidosis, a rare blood cell disorder associated with the deterioration of vital organs, most notably the heart, kidneys and liver.[1] Longer-term results from a median follow-up of 20.3 months showed rates of hematologic complete response (hemCR) remained significantly higher in patients treated with DARZALEX FASPRO®...
Source: Johnson and Johnson - May 26, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen ’s Updated Phase 1 Results for Teclistamab Suggest Deep, Durable Responses in Patients with Heavily Pretreated Multiple Myeloma
We reported initial findings for teclistamab at ASCO 2020, and study updates have observed a deepening of responses that have shown to be durable in a significant percentage of patients with relapsed or refractory multiple myeloma,” said Amrita Y. Krishnan, M.D., Director of the Judy and Bernard Briskin Center for Multiple Myeloma Research and Chief, Division of Multiple Myeloma, Department of Hematology and Hematopoietic Cell Transplantation at City of Hope, and study investigator. “Teclistamab exposure was sustained across the dosing interval and exceeded target levels, and consistent T-cell activation was ob...
Source: Johnson and Johnson - May 24, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Artificial heart co. Bivacor nabs $22M in Series B, grant funding
Houston heart surgeon and health care entrepreneur Dr. Billy Cohn serves as chief medical officer for Bivacor, which is working toward starting the first human studies using its artificial heart device. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 19, 2021 Category: American Health Authors: Chris Mathews Source Type: news

Artificial heart co. Bivacor nabs $22M in Series B, grant funding
Houston heart surgeon and health care entrepreneur Dr. Billy Cohn serves as chief medical officer for Bivacor, which is working toward starting the first human studies using its artificial heart device. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 19, 2021 Category: Biotechnology Authors: Chris Mathews Source Type: news

London's Royal Free Hospital to use AI keyhole procedure for heart attack patients
Heart attack patients at the Royal Free Hospital in London are to benefit from a new  artificial intelligence (AI) backed keyhole procedure. Abbott Ultreon 1.0 software merges optical coherence tomography (OCT), an imaging tool that provides cardiologists a view inside an artery or blood vessel, with AI technology for enhanced visualisation. (Source: mobihealthnews)
Source: mobihealthnews - May 18, 2021 Category: Information Technology Source Type: news

Late-Breaking Data at ACC.21 Show XARELTO ® (rivaroxaban) Plus Aspirin Significantly Reduced Total Ischemic Events in Peripheral Artery Disease (PAD) Patients After Lower-Extremity Revascularization
RARITAN, N.J., May 16, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today presented new data from the Phase 3 VOYAGER PAD study which showed XARELTO® (rivaroxaban) (2.5 mg twice daily) in combination with aspirin (100 mg once daily) consistently reduced severe vascular events in patients with peripheral artery disease (PAD) after lower-extremity revascularization (LER) compared to aspirin alone regardless of whether it was the first, second, third, or subsequent event. The primary results of VOYAGER PAD showed that XARELTO® plus aspirin reduced first events by 15 percent among patients...
Source: Johnson and Johnson - May 16, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Heart transplant patient: “I’m going to see my grandson grow up!”
Advancing heart problems had become so serious for James Fowler that his doctors suggested he make sure his funeral arrangements were in order. Looking for hope, he turned to the team of heart specialists at Wake Forest Baptist Health. They implanted a device that stabilized his heart and kept it pumping until he could get a heart transplant. With a new heart, Fowler has a new lease on life. “I’m going to see my grandson grow up!” Learn more about Wake Forest Baptist’s Heart and Vascular… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 15, 2021 Category: American Health Authors: Wake Forest Baptist Health Source Type: news

Heart transplant patient: “I’m going to see my grandson grow up!”
Advancing heart problems had become so serious for James Fowler that his doctors suggested he make sure his funeral arrangements were in order. Looking for hope, he turned to the team of heart specialists at Wake Forest Baptist Health. They implanted a device that stabilized his heart and kept it pumping until he could get a heart transplant. With a new heart, Fowler has a new lease on life. “I’m going to see my grandson grow up!” Learn more about Wake Forest Baptist’s Heart and Vascular… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 15, 2021 Category: Biotechnology Authors: Wake Forest Baptist Health Source Type: news

Can AI help detect congenital heart disease on fetal ultrasound?
An artificial intelligence (AI) model can significantly improve the detectio...Read more on AuntMinnie.comRelated Reading: Fetal cardiovascular MRI helps diagnose congenital heart defects 4D MRI could be big leap forward for fetal heart imaging 3D printing can help in planning complex CHD surgeries CNN cuts interpretation time for 4D flow cardiac MRI Imaging criteria for congenital heart disease released (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 14, 2021 Category: Radiology Source Type: news

Gene therapy offers potential cure to children born without an immune system
An experimental form of gene therapy developed by a team of researchers from UCLA and Great Ormond Street Hospital in London has successfully treated 48 of 50 children born with a rare and deadly inherited disorder that leaves them without an immune system.Severe combined immunodeficiency due to adenosine deaminase deficiency, or ADA-SCID, is caused by mutations in theADA gene that creates the enzyme adenosine deaminase, which is essential to a functioning immune system.For children with the condition, even day-to-day activities like going to school or playing with friends can lead to dangerous, life-threatening infections...
Source: UCLA Newsroom: Health Sciences - May 11, 2021 Category: Universities & Medical Training Source Type: news

Molecular analysis identifies key differences in lungs of cystic fibrosis patients
A team of researchers from UCLA, Cedars-Sinai and the Cystic FibrosisFoundation has developed a first-of-its-kind molecular catalog of cells in healthy lungs and the lungs of people with cystic fibrosis.The catalog,described today in the journal Nature Medicine, reveals new subtypes of cells and illustrates how the disease changes the cellular makeup of the airways. The findings could help scientists in their search for specific cell types that represent prime targets for genetic and cell therapies for cystic fibrosis.“This new research has provided us with valuable insights into the cellular makeup of both heal...
Source: UCLA Newsroom: Health Sciences - May 7, 2021 Category: Universities & Medical Training Source Type: news

Heart Retrieval Technique May Boost Organs for Transplant by 20% Heart Retrieval Technique May Boost Organs for Transplant by 20%
Pilot data on eight heart transplants using cardiopulmonary bypass for immediate regional reperfusion and cardiac unloading show the approach is feasible; if confirmed, it could increase the organ pool by 20%.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - May 6, 2021 Category: Internal Medicine Tags: Cardiology News Source Type: news

RSIP Vision debuts prostate AI registration tool
Computer software and artificial intelligence (AI) company RSIP Vision has unveile...Read more on AuntMinnie.comRelated Reading: RSIP releases new CT segmentation software for orthopedics RSIP Vision launches coronary artery tool RSIP Vision unveils AI-based image segmentation tool RSIP Vision launches new heart POC ultrasound RSIP Vision launches AI-based ultrasound tools (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 4, 2021 Category: Radiology Source Type: news

Study finds heart transplantation using donation after cardiac death with NRP
(American Association for Thoracic Surgery) A new study, presented today at the AATS 101st Annual Meeting, found that heart transplantation using donation after cardiac death (DCD) with normothermic regional perfusion (NRP) is feasible in the United States. Broader application of DCD heart transplantation has the potential to increase cardiac allograft availability by 20-30 percent. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 2, 2021 Category: International Medicine & Public Health Source Type: news

We Need More Data in the Fight Against Cancer. Here ’s a Plan to Help Us Get There
For the first time in over a year, we are starting to see a light at the end of the tunnel from the devastation caused by COVID-19. While much work remains to end and avoid a resurgence of the pandemic, public and private investments in scientific research will get us to a new normal. The speed to develop, test and manufacture COVID-19 vaccines has shown how science and technology, supported by leadership from governments and the private sector, have the ability to save lives. For example, the CDC’s V-safe program, which recorded side effects, led to the collection of data from tens of millions of people after vaccin...
Source: TIME: Health - April 29, 2021 Category: Consumer Health News Authors: Dr. David B. Agus, Dr. Elizabeth M. Jaffee, and Dr. Chi Van Dang Tags: Uncategorized Source Type: news

Mayo Clinic Q & amp;A podcast: Reducing rejection by reversing order of heart-liver transplant
For heart-liver transplants, the liver and heart must come from the same donor, and some patients wait years to receive both organs. Also, antibodies from the donor can increase chances of the receiving patient rejecting the heart. But Dr. Sudhir Kushwaha, a Mayo Clinic cardiovascular transplant surgeon, says when a liver transplant is also involved, [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 27, 2021 Category: Databases & Libraries Source Type: news

Scientists in California, Texas to study ways to help children receiving heart transplants
(American Heart Association) Scientific research teams in California and Texas have been awarded nearly $1.4 million in grants to study ways to improve pediatric heart transplant outcomes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 20, 2021 Category: International Medicine & Public Health Source Type: news